Skip to Main Content

Paper Details

Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer.
Eur Urol Oncol
0
2023
/, BRCA2, BRCA2 mutation, BRCA2mut, Metastatic Castration-Resistant Prostate Cancer, PARP, PSA, Poly (ADP-ribose), Poly (ADP-ribose) Polymerase, SBS3, SPOP, SPOP Mutations, SPOP mutation, SPOP mutations, SPOPmut, SPOPwt, androgen, androgen receptor, coaltered disease, mCRPC, metastatic castration-resistant prostate cancer, patients, poly (ADP-ribose), poly (ADP-ribose) polymerase, prostate-specific antigen, speckle-type POZ protein, taxane, tumor
Author NameAffiliation
Alok K TewariDana-Farber Cancer Institute, Harvard Medical School
Irbaz Bin RiazMayo Clinic
Mary-Ellen TaplinDana-Farber Cancer Institute, Harvard Medical School
Rahul AggarwalUniversity of California San Francisco
Niven MehraRadboud University
Peter S NelsonUniversity of Washington and Fred Hutchinson Cancer Center
Peter S NelsonUniversity of Washington and Fred Hutchinson Cancer Center
Emmanuel S AntonarakisUniversity of Minnesota, USA Masonic Cancer Center
  • 1 - 8

Datasets

Release 1.2